SLCTR_2018_019
Effects of delta-tocotrienol, resveratrol and vitamin D supplementation mixture on biochemical markers in diabetic patients
Synergistic Effects of delta-Tocotrienol, Resveratrol and Vitamin D Supplementation on Modulation of Biochemical Markers, Cytokines and miRNAs in patients of type 2 diabetes mellitus
Higher Education Commission (HEC) Pakistan·Phase 4·Sri Lanka Clinical Trials RegistryRecruiting
Study focus
- Disease/Condition
- Type 2 Diabetes mellitus
- Study type
- Interventional
Sponsor & location
- Primary sponsor
- Higher Education Commission (HEC) Pakistan
- Location
- Pakistan
Timeline & enrollment
- Phase
- Phase 4
- Start date
- Jun 28, 2018
- End date
- N/A
ICD-10 classifications
Type 2 diabetes mellitusType 2 diabetes mellitus with unspecified complicationsType 2 diabetes mellitus with other specified complicationsType 2 diabetes mellitus without complicationsType 2 diabetes mellitus with multiple complications
Data source
- Registry
- Sri Lanka Clinical Trials Registry
- Trial ID
- SLCTR_2018_019
- Type
- Non-Device Trial
About this record
Access comprehensive clinical trial information for SLCTR_2018_019 through Pure Global AI's free database. This Phase 4 trial is sponsored by Higher Education Commission (HEC) Pakistan and is currently Recruiting. The study focuses on Type 2 Diabetes mellitus.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to Sri Lanka Clinical Trials Registry data, helping medical device and pharmaceutical companies navigate clinical research efficiently.